← Product Code [DPS](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS) · K103077

# ECG PEN (K103077)

_Meridian Dynamics Biomedical, Inc. · DPS · Jul 13, 2011 · Cardiovascular · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K103077

## Device Facts

- **Applicant:** Meridian Dynamics Biomedical, Inc.
- **Product Code:** [DPS](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS.md)
- **Decision Date:** Jul 13, 2011
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 870.2340
- **Device Class:** Class 2
- **Review Panel:** Cardiovascular

## Indications for Use

The Vion.ECG Pen (Model no.: 800E) is intended for recording ECG data and displaying general information by adult patients who are concerned their hearter hythm and waveform. This Vion.ECG Pen allows the patients to record transient cardiac events voluntarily for providing to the healthcare professionals as references during office visits. In addition, the patient can also record their ECG data and transmit the recorded data to personal computer. The Vion.ECG Pen is not intended for recording and transmission of user's ECG signal simultaneously. Users with implanted pacemakers are not recommended to use this device. This device is not intended to substitute a conventional diagnostic tool.

## Device Story

Small, portable, leadless electrocardiograph; records 30-second ECG measurements; stores up to 99 readings with date/time stamps. Operated by patient to capture transient cardiac events; data transferred via USB to personal computer for physician review during office visits. Assists healthcare professionals in monitoring patient heart rhythm; not a substitute for conventional diagnostic tools. Benefits include non-invasive, convenient documentation of cardiac symptoms.

## Clinical Evidence

Clinical investigation compared Vion.800E to 12-lead standard ECG (PHILIPS PageWriter Trim II) in 206 patients. Evaluated performance metrics including heart rate, QRS interval, QT interval, PR interval, R-wave, S-wave, and T-wave. Results indicated performance is comparable to 12-lead ECG for recording and displaying general ECG information.

## Technological Characteristics

Portable, leadless ECG recorder; USB interface for data transfer; internal memory for 99 measurements. Conforms to IEC 60601-1 (safety), IEC 60601-1-2 (EMC), IEC 60601-2-25, and IEC 60601-2-47 (performance).

## Regulatory Identification

An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.

## Predicate Devices

- Omron HCG-801 portable ECG Monitor ([K060766](/device/K060766.md))
- MD100 Handheld ECG Monitor ([K080933](/device/K080933.md))

## Reference Devices

- PHILIPS PageWriter Trim II Cardiograph

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

KI 03077

## 510(K) SUMMARY

JUL 1 3 2011

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA and 21 CFR §807.92.

1.0 Submitter's Name: Meridian Dynamics Biomedical, Inc. (MD Biomedical, Inc.) 3E No 100.Sec 3. Mingsheng E. Rd., Taipei, Taiwan, 105 Address:

| Address: | 3F,NO 100,Sec 3, Mingsheng E. Rd., Taipei, Taiwan, 105 |
|----------|--------------------------------------------------------|
| Tel:     | +886-2-27183000 Ext.103                                |
| Fax:     | +886-2-27180123                                        |
| Contact: | Carl Yu/Vice President                                 |
| E-Mail:  | carl@mdbiomedical.com                                  |

- 2.0 Device Name Vion® ECG Pen(Model no .: 800E) Trade Name: Handheld ECG monitor Common Name: Electrocardiograph Classification name:
- 3.0 Classification: Class II DPS Product Code: 21CFR870.2340 Regulation No.:
- The predicate device is the Omron HCG-801 portable ECG 4.0 Predicate Device: Monitor (K060766) marketed by Omron Healthcare, Inc. & MD100 Handheld ECG Monitor (K080933) marketed by Beijing Choice Electronic Technology Co., Ltd..
- The Vion.ECG Pen (Model no.: 800E) is intended for 5.0 Intended Use: recording ECG data and displaying general information by adult patients who are concerned their heart rhythm and waveform. This Vion,ECG Pen allows the patients to record transient cardiac events voluntarily for providing to the healthcare professionals as references during office visits.

In addition, the patient can also record their ECG data and transmit the recorded data to personal computer.

The Vion.ECG Pen is not intended for recording and transmission of user's ECG signal simultaneously. Users with implanted pacemakers are not recommended to use this

Product: Vion. 800E ECG Pen by MD Biomedical, Inc. Section 4 - 510(k) Summary REV. 【C】 Page 1 of 3

{1}------------------------------------------------

device. This device is not intended to substitute a conventional diagnostic tool.

6.0 Device Description: The MD's Vion.800E ECG Pen is a small, portable and easy-to-use electrocardiograph unit that can record and store electrocardiogram (ECG) measurements of your heart rhythm. Each ECG reading records 30 seconds measurement and these ECG readings can help your doctor monitor your condition.

> The unit included build-in memory that can store up to 99 measurements, including the ECG data along with date and time of measurement. With USB interface, it allows you or your doctor to view detail information of measurement.

> Furthermore, Vion® ECG Pen (Model no.: 800E) has similar general design with the Omron HCG-801 portable ECG Monitor (K060766 ) marketed by Omron Healthcare, Inc.. & MD100 Handheld ECG Monitor (K080933) marketed by Beijing Choice Electronic Technology Co., Ltd.

In terms of operating specification, Safety & EMC 7.0 Non-Clinical Performance Tests requirements, the device conforms to applicable standards include Summary: All Safety test: according to IEC 60601-2-25 & IEC

| All Burst, test:  | 60601-1,                    |
|-------------------|-----------------------------|
| EMC test:         | according to IEC 60601-1-2  |
| Performance test: | according to IEC 60601-2-47 |

A Clinical Investigation study was performed in such a way 8.0 Clinical test that compared the performance , including Heart rate. QRS Summary: interval, OT interval, PR interval, R-wave, S-wave, T-wave --------etc., between single channel patient-activated ECG device "Vion.800E" VS. 12-lead standard ECG "PHILIPS, PageWriter Trim II Cardiograph. 206 patients are involved in this study.

> According to the clinical investigation results and discussion, the performance of Vion.ECG Pen (Model: Vion.800E) is as

Product: Vion. 800E ECG Pen by MD Biomedical, Inc. Section 4 - 510(k) Summary REV. (C) Page 2 of 3

{2}------------------------------------------------

good as the 12-lead ECG (PHILIPS, PageWriter Trim II Cardiograph) in recording ECG data and displaying general information.

The patient-activated ECG system used in this study is a leadless recorder, which records 30 seconds ECG signal. The time it costs for use is much shorter than other conventional ECG recorders, and requires no external wires and electrodes. Therefore, the patient-activated ECG recorder, Vion.800E, is ideal to be used to document the behavior of rhythm and signal waveform during symptoms in order to replace a more expensive and invasive diagnostic procedures.

## Conclusions:

Vion® ECG Pen (Model no.: 800E) has the same intended use, principles of operation, and similar technological characteristics as predicate devices. Moreover, bench testing contained in this submission demonstrates that any differences in their technological characteristics do not raise any new questions of safety or effectiveness. Thus, the Vion® ECG Pen (Model no.: 800E) is substantially equivalent to the predicate devices.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird symbol with three curved lines representing its wings or body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird symbol.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Meridian Dynamics Biomedical, Inc. C/O Jennifer Reich Harvest Consulting Corp. 2904 N. Boldt Drive Flagstaff, AZ 86001

JUL 1 3 2011

Re: K103077

Trade/Device Name: ECG Pen Regulation Number: 21 CFR 870.2340 Regulation Name: Electrocardiograph Regulatory Class: Class II Product Code: DPS Dated: June 14, 2011 Received: June 24, 2011

Dear Ms. Reich:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it ' may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must

{4}------------------------------------------------

Page 2 – Ms. Jennifer Reich

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.html for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Bryan D. Zuckerman, M.D.

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

## Indications for Use

510(k) Number (if known): ___K103077

Device Name: Vion.® 800E ECG Pen MD Biomedical, Inc.

Indications for Use:

The Vion.ECG Pen (Model no.: 800E) is intended for recording ECG data and displaying general information by adult patients who are concerned their hearter hythm and waveform. This Vion.ECG Pen allows the patients to record transient cardiac events voluntarily for providing to the healthcare professionals as references during office visits.

In addition, the patient can also record their ECG data and transmit the recorded data to personal computer.

The Vion.ECG Pen is not intended for recording and transmission of user's ECG signal simultaneously. Users with implanted pacemakers are not recommended to use this device. This device is not intended to substitute a conventional diagnostic tool.

| Prescription Use<br>(Part 21 CFR 801 Subpart D) | V | AND/OR | Over-The-Counter Use<br>(21 CFR 807 Subpart C) |  |
|-------------------------------------------------|---|--------|------------------------------------------------|--|
|-------------------------------------------------|---|--------|------------------------------------------------|--|

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)

Division of Cardiovascular Devices

| 510(k) Number | K103077 |
|---------------|---------|
|---------------|---------|

Page 1 of 1

---

**Source:** [https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K103077](https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K103077)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com